Planet Green Holdings Corp. (NYSEAMERICAN:PLAG) Short Interest Update

Planet Green Holdings Corp. (NYSEAMERICAN:PLAG) saw short interest fall in May, down 42.3% to 58,338 shares as of May 15 from 101,177 on April 30, according to the update. Days to cover was 1.3 based on average volume of 44,943; 0.8% of shares were short. The stock rose 1.9% to $1.60.

Original reporting
Published Jun 4, 2026, 6:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 4, 2026, 6:59 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Planet Green Holdings Corp. (NYSEAMERICAN:PLAG) Short Interest Update — source image
Decision brief

The 30-second read

$PLAGBullishMed
01

Why it matters

A 42.3% decline in short interest suggests reduced bearish exposure as of May 15, potentially supporting the stock if shorts continue to unwind.

02

Market read

Traders may treat the May short-interest reduction as a positioning tailwind, but without a new operating catalyst it is likely secondary to liquidity and broader risk appetite.

03

What to watch

The article notes very small market cap and thin volume; microstructure effects can dominate any short-interest signal.

Relevance 7/10Novelty 6/10Timing: Today’s trading context after the May 15 short-interest print and Thursday’s +1.9% move.

Background

The article summarizes PLAG’s monthly short-interest change and provides a snapshot of recent trading and the last reported quarterly EPS/revenue.

Company-level read

Ticker impact

$PLAGBullishMedium confidence
Context

Article reports a sharp May decline in PLAG short interest (42.3%) alongside current days-to-cover of 1.3, plus the stock’s +1.9% move.

Expected impact

Mildly bullish bias for near-term trading; follow-through depends on whether the short-covering trend continues.

Evidence & confidence

The piece provides a concrete short-interest datapoint and current trading snapshot, but no new earnings/guidance catalyst beyond a previously reported EPS figure.

Market effects

Limited sector read-across; this is company-specific positioning data rather than an industry catalyst.

No clear regional spillover indicated.

No global relevance beyond the issuer’s capital-markets positioning.

Counterpoint

Short interest can fall for reasons other than bullish conviction (e.g., liquidity/positioning changes), so price may not sustain.

Key entities

  • Planet Green Holdings Corp.

    Subject of the short-interest update and the reported +1.9% Thursday price move.

Related articles

$PLAGLow

Planet Green Holdings Corp. (PLAG): Completion of Acquisition or Disposition of Assets

Planet Green Holdings Corp. (PLAG) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. EX-99.1 2 ea029399001ex99-1.htm UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL INFORMATION Exhibit 99.1 UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL INFORMATION Introduction The following unaudited pro forma condensed consolidated balance sheet as of March 31, 2026

$AVGOMed

Why Broadcom Stock Inched Higher on Friday

Broadcom (AVGO) stock rose 1.2% on Friday, outperforming the S&P 500, after BMO Capital Markets initiated coverage with an outperform rating and a $455 price target. Analyst Harsh Kumar ranked Broadcom second in the semiconductor sector, citing the growing AI trend. J.P. Morgan's Nikolaos Panigirtzoglou also noted AI-related revenue supporting capital expenditures.

$AMLXHighAI 9/10

Why Amylyx Pharmaceuticals Blasted Nearly 79% Higher This Week

Amylyx Pharmaceuticals' stock surged nearly 79% after positive Phase 3 trial results for avexitide, a drug targeting post-bariatric hypoglycemia. The company also announced a $500 million secondary stock offering. Analysts raised price targets, with Guggenheim's Seamus Fernandez setting a new target of $55 per share. The stock closed at $38.66, giving the company a market cap of $4.4 billion.

$CRMLHigh

Why Did Critical Metals Stock Just Gain 22.6%?

Critical Metals (CRML) rose 22.6% after its CEO confirmed the Tanbreez project in Greenland is on track for rare-earth production within three years. The company also detailed its acquisition of European Lithium, increasing its stake to 100%. The U.S. government has shown interest in rare-earth mining, but CRML is pre-revenue and faces a long timeline to production.

$AMLXMed

Amylyx (AMLX) Faces a Binary Phase 3 Test. Can Avexitide Rebuild the Company?

Amylyx Pharmaceuticals (AMLX) released Phase 3 LUCIDITY trial results for avexitide, a treatment for post-bariatric hypoglycemia. Shares rose 15.7% after-hours. The trial's success could validate Amylyx's shift to endocrine disease, while failure may refocus attention on earlier-stage programs. The company has $250.8M in cash, sufficient until 2028. Avexitide has Breakthrough Therapy designation, with a potential 2027 launch if approved.